FDA Approves First Generic Cyclosporine Oral Solution for Cats for Treatment of Allergic Dermatitis
Today, the U.S. Food and Drug Administration approved Modulis for Cats, the first generic cyclosporine oral solution for cats. Modulis for Cats is indicated for the control of certain skin conditions resulting from a disease called feline allergic dermatitis.
Cats with feline allergic dermatitis may be intensely itchy and lick, chew and scratch at their skin and hair. As a result, affected cats can develop excoriations (due to the cat scratching itself), miliary dermatitis (a skin condition in cats that most commonly is due to allergic reaction), eosinophilic plaques (skin lesions), and self-induced alopecia (hair loss).
You are subscribed to updates from FDA's Center for Veterinary Medicine.
|